324 related articles for article (PubMed ID: 7723550)
1. Prognostic classification of breast ductal carcinoma-in-situ.
Silverstein MJ; Poller DN; Waisman JR; Colburn WJ; Barth A; Gierson ED; Lewinsky B; Gamagami P; Slamon DJ
Lancet; 1995 May; 345(8958):1154-7. PubMed ID: 7723550
[TBL] [Abstract][Full Text] [Related]
2. Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.
Poller DN; Silverstein MJ; Galea M; Locker AP; Elston CW; Blamey RW; Ellis IO
Mod Pathol; 1994 Feb; 7(2):257-62. PubMed ID: 7911998
[TBL] [Abstract][Full Text] [Related]
3. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
4. Use of predictors of recurrence to plan therapy for DCIS of the breast.
Silverstein MJ; Lagios MD
Oncology (Williston Park); 1997 Mar; 11(3):393-406, 409-10; discussion 413-5. PubMed ID: 9109132
[TBL] [Abstract][Full Text] [Related]
5. Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European Commission Working Group on Breast Screening Pathology.
Sloane JP; Amendoeira I; Apostolikas N; Bellocq JP; Bianchi S; Boecker W; Bussolati G; Coleman D; Connolly CE; Dervan P; Eusebi V; De Miguel C; Drijkoningen M; Elston CW; Faverley D; Gad A; Jacquemier J; Lacerda M; Martinez-Penuela J; Munt C; Peterse JL; Rank F; Sylvan M; Tsakraklides V; Zafrani B
Hum Pathol; 1998 Oct; 29(10):1056-62. PubMed ID: 9781641
[TBL] [Abstract][Full Text] [Related]
6. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.
Boyages J; Delaney G; Taylor R
Cancer; 1999 Feb; 85(3):616-28. PubMed ID: 10091735
[TBL] [Abstract][Full Text] [Related]
7. Classification of duct carcinoma in situ (DCIS) with a characterization of high grade lesions: defining cohorts for chemoprevention trials.
Lagios MD
J Cell Biochem Suppl; 1996; 25():108-11. PubMed ID: 9027606
[TBL] [Abstract][Full Text] [Related]
8. Ductal carcinoma in situ of the breast: reproducibility of histological subtype analysis.
Scott MA; Lagios MD; Axelsson K; Rogers LW; Anderson TJ; Page DL
Hum Pathol; 1997 Aug; 28(8):967-73. PubMed ID: 9269834
[TBL] [Abstract][Full Text] [Related]
9. A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS): correlation with grade of associated invasive carcinoma.
Douglas-Jones AG; Gupta SK; Attanoos RL; Morgan JM; Mansel RE
Histopathology; 1996 Nov; 29(5):397-409. PubMed ID: 8951484
[TBL] [Abstract][Full Text] [Related]
10. Influence of local treatment on the recurrence rate of ductal carcinoma in situ.
Warneke J; Grossklaus D; Davis J; Stea B; Bebb G; Taylor C; Hastings R; Villar H
J Am Coll Surg; 1995 Jun; 180(6):683-8. PubMed ID: 7773481
[TBL] [Abstract][Full Text] [Related]
11. Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery.
Boland GP; Chan KC; Knox WF; Roberts SA; Bundred NJ
Br J Surg; 2003 Apr; 90(4):426-32. PubMed ID: 12673743
[TBL] [Abstract][Full Text] [Related]
12. Analyzing the risk of recurrence after mastectomy for DCIS: a new use for the USC/Van Nuys Prognostic Index.
Kelley L; Silverstein M; Guerra L
Ann Surg Oncol; 2011 Feb; 18(2):459-62. PubMed ID: 20859695
[TBL] [Abstract][Full Text] [Related]
13. Ductal carcinoma in situ. The success of breast conservation therapy: a shared experience of two single institutional nonrandomized prospective studies.
Lagios MD; Silverstein MJ
Surg Oncol Clin N Am; 1997 Apr; 6(2):385-92. PubMed ID: 9115503
[TBL] [Abstract][Full Text] [Related]
14. [Ductal hyperplasia and ductal carcinoma in situ. Definition--classification--differential diagnosis].
Böcker W; Decker T; Ruhnke M; Schneider W
Pathologe; 1997 Jan; 18(1):3-18. PubMed ID: 9157402
[TBL] [Abstract][Full Text] [Related]
15. The clinical behavior of breast carcinoma is probably determined at the preinvasive stage (ductal carcinoma in situ).
Gupta SK; Douglas-Jones AG; Fenn N; Morgan JM; Mansel RE
Cancer; 1997 Nov; 80(9):1740-5. PubMed ID: 9351542
[TBL] [Abstract][Full Text] [Related]
16. Consensus conference on the classification of ductal carcinoma in situ.
Hum Pathol; 1997 Nov; 28(11):1221-5. PubMed ID: 9385925
[No Abstract] [Full Text] [Related]
17. Cancerization of lobules and atypical ductal hyperplasia adjacent to ductal carcinoma in situ of the breast.
Goldstein NS; Lacerna M; Vicini F
Am J Clin Pathol; 1998 Sep; 110(3):357-67. PubMed ID: 9728611
[TBL] [Abstract][Full Text] [Related]
18. A proposal for the histopathological diagnosis of ductal carcinoma in situ of the breast.
Moriya T; Kasami M; Akiyama F; Ichihara S; Kurosumi M; Tsuda H; Umemura S; Akashi-Tanaka S; Imamura H; Iwase H; Shin E; Harada Y; Mitsuyama S; Ohuchi N
Breast Cancer; 2000; 7(4):321-5. PubMed ID: 11114858
[TBL] [Abstract][Full Text] [Related]
19. Pathology and clinical evolution of ductal carcinoma in situ (DCIS) of the breast.
Page DL; Lagios MD
Cancer Lett; 1994 Oct; 86(1):1-4. PubMed ID: 7954344
[TBL] [Abstract][Full Text] [Related]
20. [In situ ductal carcinoma of the breast: current status and our experience].
Friedman D; Sorice G; Baccini P; Varcada M; Percoco P; Bachi V
Ann Ital Chir; 1999; 70(1):37-43; discussion 44. PubMed ID: 10367505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
